Improvements in Health-Related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western countries,1 and accounts for approximately one-third of new leukemia cases in the United States each year.2 It is seen mainly in older adults, with an average age at diagnosis of 70 years.3
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Original article Source Type: research